Jinhua Mayor Xing Zhihong to Peak Research
Release time:
2022-06-13
1 , Jinhua Mayor Xing Zhihong, Wucheng District Party Committee Secretary Gao Feng and District Mayor Hu Yuxian, and heads of departments such as the Municipal Economic and Information Bureau and the Development and Reform Bureau went to the group headquarters to have a discussion and exchange with the leaders of the group company to understand the development of the enterprise and solicit the opinions and suggestions of the enterprise on the work of the government. After understanding the current business situation of the peak, Xing Zhihong pointed out that focus, follow the right path, frontier, steady, is the peak to long-term prosperity of the magic weapon, must continue to adhere.
In the survey, Jiang Xiaomeng, chairman of the group company, combined with the current economic situation, gave a detailed introduction to the company's current production and operation status and future development plans. He said that since the beginning of this year, the new coronary pneumonia epidemic is complex and changeable, which has brought serious impact on the economic development of various places. In response to this situation, the company's management team has unified its thinking, and all enterprises have made every effort to grasp three things, namely, to grasp market sales, to reduce costs and increase efficiency, to grasp technological innovation, and to break through the dilemma by striving to create the core competitive advantage of the peak. This approach was unanimously agreed by the visiting city and district leaders.Jiang Xiaomeng, Yu Jianhong and other group leaders also made reports and exchanges with Xing Zhihong and his party on the current business environment, government and enterprise policy coordination and other topics.
Xing Zhihong said after listening to the report, the peak is Jinhua's leading enterprises, leading enterprises, in this year due to the epidemic caused by the economic downturn in the environment, can really achieve steady progress, it is gratifying. Judging from the good development trend of Jianfeng in recent years, there are several experiences worth learning from other enterprises, namely: focus, stick to the main business, focus on the areas they are good at, and strengthen the core competitiveness of the enterprise itself; take the right path, do not speculate, insist on considering problems from the long-term development of the enterprise, make products from quality and reputation, consolidate customers, establish brand and market, and earnestly build a century-old enterprise, with a forward-looking vision, we should keep a close eye on the forefront of the industry, technology and management, and constantly explore to expand the space for greater development in the future; we have established a scientific management decision-making system and governance structure, avoided the blindness of operation and management, and achieved stable and orderly development. These four key elements are the magic weapon for the long-term prosperity of the peak, and we must continue to adhere to it for a long time.
Xing Zhihong pointed out that the current economic development is in a special period. The epidemic prevention work cannot be relaxed, the market pressure is high, and the market competition pattern and competition form have undergone tremendous changes. As a leading enterprise in Jinhua City, Jianfeng must be in business development. Set an example, adhere to the research and investment of scientific and technological innovation, adhere to the expansion and extension of the industrial chain and value chain, and strive for the right to speak and initiative in market competition. Governments at all levels in Jinhua will also earnestly understand what enterprises want and need, and continue to optimize and improve in policy formulation and communication and service coordination for enterprises, so as to fundamentally solve problems for enterprises, help enterprises develop healthily, and consolidate the foundation of Jinhua's industrial development.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page